Related Experiment Videos
Computed tomographic evaluation and staging of cecal carcinoma
Summary
Computed tomography (CT) scans for cecal adenocarcinoma often underestimate disease extent, particularly for lymph node metastasis. While CT shows high positive predictive value, it frequently fails to detect all involved nodes, impacting accurate staging.
Area of Science:
- Oncology
- Radiology
- Gastroenterology
Background:
- Primary adenocarcinoma of the cecum requires accurate staging for effective treatment planning.
- Computed tomography (CT) is a common preoperative imaging modality for assessing gastrointestinal cancers.
Purpose of the Study:
- To evaluate the clinical presentation, CT findings, and accuracy of CT staging for primary adenocarcinoma of the cecum.
- To assess the value of preoperative CT scans in determining tumor invasion and lymph node metastasis.
Main Methods:
- Review of preoperative computed tomographic (CT) scans from 14 patients with biopsy-proven primary adenocarcinoma of the cecum.
- Correlation of CT findings with histopathology, focusing on tumor invasion beyond the bowel wall and nodal involvement.
- Assessment of CT tumor staging accuracy compared to final pathological staging.
Main Results:
- CT showed a sensitivity of 78% for detecting tumor invasion beyond the bowel wall, with a negative predictive value of 33%.
- CT demonstrated low sensitivity (12%) and a negative predictive value of 22% for detecting metastatic nodal involvement, with key nodal chains often not discernible.
- CT tumor staging accuracy was 57%, with 43% of cases being upgraded, indicating underestimation of disease extent.
Conclusions:
- Preoperative CT scans for cecal adenocarcinoma have limitations in accurately staging disease extent, particularly regarding lymph node metastasis.
- CT tends to underestimate the true extent of disease, despite high predictive values for positive findings.
- The study highlights the need for improved imaging or complementary diagnostic methods for comprehensive staging of cecal adenocarcinoma.